Advertisement

Topics

CNS Refresh: Boehringer's New Approach To Tricky Neuropsychiatry Diseases

08:18 EST 13 Nov 2017 | SCRIP

Boehringer Ingelheim is seeking partners with early-stage, novel approaches to neuropsychiatry disorders under its strategy of applying "fresh thinking" to...

      

Related Stories

 

Original Article: CNS Refresh: Boehringer's New Approach To Tricky Neuropsychiatry Diseases

NEXT ARTICLE

More From BioPortfolio on "CNS Refresh: Boehringer's New Approach To Tricky Neuropsychiatry Diseases"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...